2519 related articles for article (PubMed ID: 16554528)
1. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
Cohen JC; Boerwinkle E; Mosley TH; Hobbs HH
N Engl J Med; 2006 Mar; 354(12):1264-72. PubMed ID: 16554528
[TBL] [Abstract][Full Text] [Related]
2. Molecular biology of PCSK9: its role in LDL metabolism.
Horton JD; Cohen JC; Hobbs HH
Trends Biochem Sci; 2007 Feb; 32(2):71-7. PubMed ID: 17215125
[TBL] [Abstract][Full Text] [Related]
3. Protease variants, LDL, and coronary heart disease.
Tall AR
N Engl J Med; 2006 Mar; 354(12):1310-2. PubMed ID: 16554535
[No Abstract] [Full Text] [Related]
4.
Kent ST; Rosenson RS; Avery CL; Chen YI; Correa A; Cummings SR; Cupples LA; Cushman M; Evans DS; Gudnason V; Harris TB; Howard G; Irvin MR; Judd SE; Jukema JW; Lange L; Levitan EB; Li X; Liu Y; Post WS; Postmus I; Psaty BM; Rotter JI; Safford MM; Sitlani CM; Smith AV; Stewart JD; Trompet S; Sun F; Vasan RS; Woolley JM; Whitsel EA; Wiggins KL; Wilson JG; Muntner P
Circ Cardiovasc Genet; 2017 Aug; 10(4):e001632. PubMed ID: 28768753
[TBL] [Abstract][Full Text] [Related]
5. Sequence variation in proprotein convertase subtilisin/kexin type 9 serine protease gene, low LDL cholesterol, and cancer incidence.
Folsom AR; Peacock JM; Boerwinkle E
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2455-8. PubMed ID: 18006936
[TBL] [Abstract][Full Text] [Related]
6. The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men.
Scartezini M; Hubbart C; Whittall RA; Cooper JA; Neil AH; Humphries SE
Clin Sci (Lond); 2007 Dec; 113(11):435-41. PubMed ID: 17550346
[TBL] [Abstract][Full Text] [Related]
7. Relation of PCSK9 mutations to serum low-density lipoprotein cholesterol in childhood and adulthood (from The Bogalusa Heart Study).
Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
Am J Cardiol; 2007 Jul; 100(1):69-72. PubMed ID: 17599443
[TBL] [Abstract][Full Text] [Related]
8. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.
Cohen J; Pertsemlidis A; Kotowski IK; Graham R; Garcia CK; Hobbs HH
Nat Genet; 2005 Feb; 37(2):161-5. PubMed ID: 15654334
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of proprotein convertase subtilisin/kexin type 9: focus on potential clinical and therapeutic implications for low-density lipoprotein cholesterol lowering.
Lose JM; Dorsch MP; Bleske BE
Pharmacotherapy; 2013 Apr; 33(4):447-60. PubMed ID: 23553812
[TBL] [Abstract][Full Text] [Related]
10. Ethnic differences in the frequency of the cardioprotective C679X PCSK9 mutation in a West African population.
Sirois F; Gbeha E; Sanni A; Chretien M; Labuda D; Mbikay M
Genet Test; 2008 Sep; 12(3):377-80. PubMed ID: 18652535
[TBL] [Abstract][Full Text] [Related]
11. A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol.
Fasano T; Cefalù AB; Di Leo E; Noto D; Pollaccia D; Bocchi L; Valenti V; Bonardi R; Guardamagna O; Averna M; Tarugi P
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):677-81. PubMed ID: 17170371
[TBL] [Abstract][Full Text] [Related]
12. PCSK9 gene mutations and low-density lipoprotein cholesterol.
Wu NQ; Li JJ
Clin Chim Acta; 2014 Apr; 431():148-53. PubMed ID: 24518357
[TBL] [Abstract][Full Text] [Related]
13. Effects of PCSK9 genetic variants on plasma LDL cholesterol levels and risk of premature myocardial infarction in the Italian population.
Guella I; Asselta R; Ardissino D; Merlini PA; Peyvandi F; Kathiresan S; Mannucci PM; Tubaro M; Duga S
J Lipid Res; 2010 Nov; 51(11):3342-9. PubMed ID: 20699424
[TBL] [Abstract][Full Text] [Related]
14. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
[TBL] [Abstract][Full Text] [Related]
15. Both rare and common variants in PCSK9 influence plasma low-density lipoprotein cholesterol level in American Indians.
Tsai CW; North KE; Tin A; Haack K; Franceschini N; Saroja Voruganti V; Laston S; Zhang Y; Best LG; MacCluer JW; Beaty TH; Navas-Acien A; Kao WH; Howard BV
J Clin Endocrinol Metab; 2015 Feb; 100(2):E345-9. PubMed ID: 25412415
[TBL] [Abstract][Full Text] [Related]
16. The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population.
Hooper AJ; Marais AD; Tanyanyiwa DM; Burnett JR
Atherosclerosis; 2007 Aug; 193(2):445-8. PubMed ID: 16989838
[TBL] [Abstract][Full Text] [Related]
17. A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.
Kotowski IK; Pertsemlidis A; Luke A; Cooper RS; Vega GL; Cohen JC; Hobbs HH
Am J Hum Genet; 2006 Mar; 78(3):410-22. PubMed ID: 16465619
[TBL] [Abstract][Full Text] [Related]
18. Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks.
Peloso GM; Auer PL; Bis JC; Voorman A; Morrison AC; Stitziel NO; Brody JA; Khetarpal SA; Crosby JR; Fornage M; Isaacs A; Jakobsdottir J; Feitosa MF; Davies G; Huffman JE; Manichaikul A; Davis B; Lohman K; Joon AY; Smith AV; Grove ML; Zanoni P; Redon V; Demissie S; Lawson K; Peters U; Carlson C; Jackson RD; Ryckman KK; Mackey RH; Robinson JG; Siscovick DS; Schreiner PJ; Mychaleckyj JC; Pankow JS; Hofman A; Uitterlinden AG; Harris TB; Taylor KD; Stafford JM; Reynolds LM; Marioni RE; Dehghan A; Franco OH; Patel AP; Lu Y; Hindy G; Gottesman O; Bottinger EP; Melander O; Orho-Melander M; Loos RJ; Duga S; Merlini PA; Farrall M; Goel A; Asselta R; Girelli D; Martinelli N; Shah SH; Kraus WE; Li M; Rader DJ; Reilly MP; McPherson R; Watkins H; Ardissino D; ; Zhang Q; Wang J; Tsai MY; Taylor HA; Correa A; Griswold ME; Lange LA; Starr JM; Rudan I; Eiriksdottir G; Launer LJ; Ordovas JM; Levy D; Chen YD; Reiner AP; Hayward C; Polasek O; Deary IJ; Borecki IB; Liu Y; Gudnason V; Wilson JG; van Duijn CM; Kooperberg C; Rich SS; Psaty BM; Rotter JI; O'Donnell CJ; Rice K; Boerwinkle E; Kathiresan S; Cupples LA
Am J Hum Genet; 2014 Feb; 94(2):223-32. PubMed ID: 24507774
[TBL] [Abstract][Full Text] [Related]
19. G-protein estrogen receptor as a regulator of low-density lipoprotein cholesterol metabolism: cellular and population genetic studies.
Hussain Y; Ding Q; Connelly PW; Brunt JH; Ban MR; McIntyre AD; Huff MW; Gros R; Hegele RA; Feldman RD
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):213-21. PubMed ID: 25395619
[TBL] [Abstract][Full Text] [Related]
20. Proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism interacts with alcohol consumption to modulate serum lipid levels.
Aung LH; Yin RX; Wu DF; Cao XL; Hu XJ; Miao L
Int J Med Sci; 2013; 10(2):124-32. PubMed ID: 23329883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
